PDRX vs JNJ: Which Stock is Better?

Side-by-side comparison of Pd-Rx Pharmaceutical and Johnson & Johnson in 2026

Comparison Updated:

PDRX

Pd-Rx Pharmaceutical

$3.35

JNJ

Johnson & Johnson

$234.18

Key Metrics Comparison

MetricPDRXJNJWinner
Market Cap$5.75M$564.35BJNJ
P/E Ratio3.1021.23PDRX
EPS (TTM)$1.08$11.03JNJ
Revenue Growth-0.0%0.1%JNJ
Gross Margin29.6%68.0%JNJ

Analyze PDRX

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PDRX or JNJ a better investment?

Comparing PDRX and JNJ: Pd-Rx Pharmaceutical has a market cap of $5.75M while Johnson & Johnson has $564.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PDRX and JNJ?

PDRX (Pd-Rx Pharmaceutical) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PDRX or JNJ?

Based on P/E ratios, PDRX trades at a lower multiple (3.1x vs 21.2x).

Which is growing faster: PDRX or JNJ?

JNJ has higher revenue growth at 0.1% vs -0.0% for PDRX.

Which company is more profitable: PDRX or JNJ?

Johnson & Johnson (JNJ) has higher gross margins at 68.0% compared to 29.6% for PDRX.

Which is the larger company: PDRX or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $564.35B compared to $5.75M for PDRX.

Should I buy PDRX or JNJ in 2026?

Both PDRX and JNJ have investment merit. PDRX trades at $3.35 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PDRX and JNJ stock?

Key differences: Market Cap ($5.75M vs $564.35B), P/E Ratio (3.1x vs 21.2x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (29.6% vs 68.0%).

Popular Stock Comparisons